Close

Deciphera Pharmaceuticals (DCPH) Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study

Go back to Deciphera Pharmaceuticals (DCPH) Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study
(NASDAQ: DCPH) Delayed: 14.18 -0.44 (3.01%)
Previous Close $14.62    52 Week High
Open $14.43    52 Week Low
Day High $14.85    P/E N/A 
Day Low $14.00    EPS
Volume 527,033